Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Specific quinone reductase 2 inhibitors reduce metabolic burden and reverse Alzheimer's disease phenotype in mice.

Autor: Gould NL; Sagol Department of Neurobiology, University of Haifa, Haifa, Israel., Scherer GR; Sagol Department of Neurobiology, University of Haifa, Haifa, Israel., Carvalho S; Wohl Institute for Drug Discovery of the Nancy and Stephen Grand Israeli National Center for Personalized Medicine (GINCPM), Weizmann Institute of Science, Rehovot, Israel., Shurrush K; Wohl Institute for Drug Discovery of the Nancy and Stephen Grand Israeli National Center for Personalized Medicine (GINCPM), Weizmann Institute of Science, Rehovot, Israel., Kayyal H; Sagol Department of Neurobiology, University of Haifa, Haifa, Israel., Edry E; Sagol Department of Neurobiology, University of Haifa, Haifa, Israel.; The Centre for Genetic Manipulation in the Brain, University of Haifa, Haifa, Israel., Elkobi A; Sagol Department of Neurobiology, University of Haifa, Haifa, Israel., David O; Sagol Department of Neurobiology, University of Haifa, Haifa, Israel., Foqara M; Sagol Department of Neurobiology, University of Haifa, Haifa, Israel., Thakar D; Sagol Department of Neurobiology, University of Haifa, Haifa, Israel., Pavesi T; Sagol Department of Neurobiology, University of Haifa, Haifa, Israel., Sharma V; Department of Biomedical Sciences, University of Windsor, Windsor, Ontario, Canada., Walker M; Department of Biochemistry, The University of Western Ontario, London, Ontario, Canada., Maitland M; Department of Biochemistry, The University of Western Ontario, London, Ontario, Canada., Dym O; Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel., Albeck S; Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel., Peleg Y; Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel., Germain N; Wohl Institute for Drug Discovery of the Nancy and Stephen Grand Israeli National Center for Personalized Medicine (GINCPM), Weizmann Institute of Science, Rehovot, Israel., Babaev I; Wohl Institute for Drug Discovery of the Nancy and Stephen Grand Israeli National Center for Personalized Medicine (GINCPM), Weizmann Institute of Science, Rehovot, Israel., Sharir H; Wohl Institute for Drug Discovery of the Nancy and Stephen Grand Israeli National Center for Personalized Medicine (GINCPM), Weizmann Institute of Science, Rehovot, Israel., Lalzar M; Bioinformatics Service Unit and., Shklyar B; Bioimaging Unit, Faculty of Natural Sciences, University of Haifa, Haifa, Israel., Hazut N; Sagol Department of Neurobiology, University of Haifa, Haifa, Israel., Khamaisy M; Sagol Department of Neurobiology, University of Haifa, Haifa, Israel., Lévesque M; Montreal Neurological Institute-Hospital and Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada., Lajoie G; Department of Biochemistry, The University of Western Ontario, London, Ontario, Canada., Avoli M; Montreal Neurological Institute-Hospital and Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada., Amitai G; Wohl Institute for Drug Discovery of the Nancy and Stephen Grand Israeli National Center for Personalized Medicine (GINCPM), Weizmann Institute of Science, Rehovot, Israel., Lefker B; Wohl Institute for Drug Discovery of the Nancy and Stephen Grand Israeli National Center for Personalized Medicine (GINCPM), Weizmann Institute of Science, Rehovot, Israel., Subramanyam C; Wohl Institute for Drug Discovery of the Nancy and Stephen Grand Israeli National Center for Personalized Medicine (GINCPM), Weizmann Institute of Science, Rehovot, Israel., Shilton B; Department of Biochemistry, The University of Western Ontario, London, Ontario, Canada., Barr H; Wohl Institute for Drug Discovery of the Nancy and Stephen Grand Israeli National Center for Personalized Medicine (GINCPM), Weizmann Institute of Science, Rehovot, Israel., Rosenblum K; Sagol Department of Neurobiology, University of Haifa, Haifa, Israel.; The Centre for Genetic Manipulation in the Brain, University of Haifa, Haifa, Israel.

Publikováno v: The Journal of clinical investigation [J Clin Invest] 2023 Oct 02; Vol. 133 (19). Date of Electronic Publication: 2023 Oct 02.

Dopamine-Dependent QR2 Pathway Activation in CA1 Interneurons Enhances Novel Memory Formation.

Autor: Gould NL; Sagol Department of Neuroscience, University of Haifa, Mount Carmel, Haifa, 3498838, Israel., Sharma V; Sagol Department of Neuroscience, University of Haifa, Mount Carmel, Haifa, 3498838, Israel., Hleihil M; Sagol Department of Neuroscience, University of Haifa, Mount Carmel, Haifa, 3498838, Israel., Kolatt Chandran S; Sagol Department of Neuroscience, University of Haifa, Mount Carmel, Haifa, 3498838, Israel., David O; Sagol Department of Neuroscience, University of Haifa, Mount Carmel, Haifa, 3498838, Israel., Edry E; Sagol Department of Neuroscience, University of Haifa, Mount Carmel, Haifa, 3498838, Israel.; Center for Gene Manipulation in the Brain, University of Haifa, Mount Carmel, Haifa, 3498838, Israel., Rosenblum K; Sagol Department of Neuroscience, University of Haifa, Mount Carmel, Haifa, 3498838, Israel kobir@psy.haifa.ac.il.; Center for Gene Manipulation in the Brain, University of Haifa, Mount Carmel, Haifa, 3498838, Israel.

Publikováno v: The Journal of neuroscience : the official journal of the Society for Neuroscience [J Neurosci] 2020 Nov 04; Vol. 40 (45), pp. 8698-8714. Date of Electronic Publication: 2020 Oct 12.

Interaction of lectins with human platelets. Effects on platelet stimulation by thrombin and ristocetin.

Autor: Ganguly P, Gould NL, Sidhu P

Publikováno v: Biochimica et biophysica acta [Biochim Biophys Acta] 1979 Sep 03; Vol. 586 (3), pp. 574-83.

Thrombin receptors of human platelets: thrombin binding and antithrombin properties of glycoprotein I.

Autor: Ganguly P, Gould NL

Publikováno v: British journal of haematology [Br J Haematol] 1979 May; Vol. 42 (1), pp. 137-45.